BWMWH - PROLANTA II
- MSDS: BWMWH
- Manufacturer: KC PHARMACEUTICALS INC
- Product Name: PROLANTA II
- National Stock Number: 6505-01-367-5263
Product Identification
Product ID:PROLANTA II
MSDS Date:12/23/1991
FSC:6505
NIIN:01-367-5263
MSDS Number: BWMWH
Responsible Party
PAMONA, CA 91768
US
Emergency Phone: 800-873-7279
Info Phone: 714-598-9499
Cage: KCPHA
Contractor
Telephone: 714-598-9499
Cage: KCPHA
Ingredients
MAGNESIUM HYDROXIDE70000
CAS: 1309-42-8
RTECS: OM3570000
ALUMINUM HYDROXIDE
CAS: 21645-51-2
RTECS: BD0940000
SILICON DIOXIDE (AMORPHOUS)
CAS: 67762-90-7
OSHA PEL 6 MG/M3
ACGIH TLV: 10 MG/M3
Hazards
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:SEE EMERGENCIES & FIRST AID.
Explanation of Carcinogenicity:MANUFACTURER GAVE NO COMMENTS OTHER THAN
THE ABOVE REFERENCES TO THE THREE LISTINGS.
Effects of Overexposure:INHALED:MAY CAUSE RESPIRATORY IRRITATION
W/COUGH. SKIN:MAY CAUSE IRRITATION,DRYNESS & DERMATITIS.
INGESTED:REACTS W/GASTRIC ACID TO GIVE ANTACID BUFFERING EFFECT
MAINTAINING GASTRIC PH OF 3.5-4.0. ING ESTION OF LARGE AMOUNTS MAY
CAUSE G/I IRRITATION W/NAUSEA,VOMITING & CONSTIPATION.
EYE:REDNESS,IRRITATION,CONJUNCTIVITIS
Medical Cond Aggravated by Exposure:MFR GAVE NO INFORMATION ON MSDS.
First Aid
First Aid:INHALED:REMOVE FROM EXPOSURE AREA. GET MEDICAL ATTENTION.
SKIN:WASH AFFECTED AREAS W/SOAP & LARGE AMOUNT WATER FOR MINIMUM OF
15-20 MIN. GET MEDICAL ATTENTION. INGESTED:GET MEDICAL ATTENTION.
EYE:WASH IMMEDIATELY W/LARGE AMOUNTS OF WATER FOR MINIMUM OF 15-20
MIN. GET MEDICAL ATTENTION.
Fire Fighting
Flash Point:NON COMBUSTIBLE
Extinguishing Media:EXTINGUISH FIRE WITH MEDIA APPROPRIATE FOR
SOUROUNDING FIRE.
Fire Fighting Procedures:REMOVE MATERIAL FROM AREA IF POSSIBLE
Accidental Release
Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTION
EQUIPMENT. WIPE WORKING SURFACE TO DRYNESS THEN WASH W/SOAP &
WATER.
Neutralizing Agent:MFR GAVE NO INFORMATION ON MSDS.
Handling
Handling and Storage Precautions:HANDLE ALL PHARMACEUTICALS PRODUCTS IN
A WAY THAT WILL AVOID CONTACT WITH & INHALATION OF DUST, FUMES,
MISTS &/OR VAPOASSOCIATED W/PRODUCT.
Other Precautions:STORE AT ROOM TEMPERATURE.
Exposure Controls
Respiratory Protection:NIOSH APPROVED RESPIRATOR.
Protective Gloves:RECOMMEND APPROPRIATE PROTECTIVE GLOVES
Eye Protection:RECOMMEND APPROPRIATE EYE PROTECTION
Other Protective Equipment:APPROPRIATE PROTECTIVE CLOTHING IS
RECOMMENDED.
Work Hygienic Practices:RECOMMENDED.
Supplemental Safety and Health
MYLOGEN II WAS HANDWRITTEN IN AS PRODUCT IN ADDITION TO PROLANTA II.
Chemical Properties
HCC:N1
NRC/State Lic Num:NONE
Spec Gravity:LEFT BLANK
pH:7-8.6
Solubility in Water:INSOLUBLE
Appearance and Odor:WHITE SUSPENSION
Stability
Stability Indicator/Materials to Avoid:YES
MALEIC ANHYDRIDE;CONTACT CAUSES EXPLOSIVE DECOMPOSITION OF MAGNESIUM
HYDROXIDE. ACIDS MAY PRODUCE EXOTHERMIC REACTION.
Stability Condition to Avoid:MFR GAVE NO INFORMATION ON MSDS.
Hazardous Decomposition Products:THERMAL DECOMPOSITION MAY RELEASE
TOXIC FUMES OF MAGNESIUM OXIDE AND ACRED SMOKE & FUMES.
Conditions to Avoid Polymerization:WILL NOT OCCUR.
Disposal
Waste Disposal Methods:DISPOSE OF I/A/W FEDERAL, STATE & LOCAL
REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.